Delek Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | $57.4M | Buy |
6,367,642
+1,230,259
| +24% | +$11.1M | 2.22% | 2 |
|
|
2019
Q1 | $80.2M | Buy |
5,137,383
+1,752,361
| +52% | +$27.3M | 3.33% | 1 |
|
|
2018
Q4 | $53.6M | Buy |
3,385,022
+1,767,313
| +109% | +$28M | 2.45% | 3 |
|
|
2018
Q3 | $34.6M | Buy |
1,617,709
+29,000
| +2% | +$621K | 1.45% | 11 |
|
|
2018
Q2 | $38.6M | Sell |
1,588,709
-154,600
| -9% | -$3.76M | 1.66% | 8 |
|
|
2018
Q1 | $29.8M | Sell |
1,743,309
-296,100
| -15% | -$5.07M | 1.53% | 9 |
|
|
2017
Q4 | $38.6M | Buy |
+2,039,409
| New | +$38.6M | 2.07% | 7 |
|